AnalystsAdnan ButtAdnan Butt's Stock Forecasts
AnalystsAdnan Butt
Analyst Ranking
Bottom 13%
#4264 out of 4870 analysts
Average Return
-19.33%
Win Rate
18%2 out of 11
Risk vs Reward
Poor
Good
Adnan Butt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Seagen IncSGEN | +46.79% | $79.37 | $116.51 | 2019-04-05 - 2020-04-03 | Buy |
Seagen IncSGEN | +45.31% | $53.79 | $78.16 | 2017-09-15 - 2018-09-14 | Buy |
Adnan Butt Analyst Color
Get additional color on Adnan Butt's coverage of popular stocks
Adnan Butt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Seagen IncSGEN | 2 | Buy | $90.00 | N/A | Maintains | 6 years ago |
Biogen IncBIIB | 2 | Hold | $325.00 | N/A | Downgrades | 6 years ago |
Iterum Therapeutics PLCITRM | 1 | Buy | $315.00 | N/A | Initiates Coverage On | 7 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 8 years ago |
Scynexis IncSCYX | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 8 years ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 8 years ago |
Medicines CoMDCO | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 8 years ago |
Curis IncCRIS | 1 | Strong Buy | $700.00 | N/A | Initiates Coverage On | 8 years ago |
Celgene CorpCELG | 1 | Strong Buy | $160.00 | N/A | Initiates Coverage On | 8 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 8 years ago |
Tesaro IncTSRO | 1 | Hold | $120.00 | N/A | Initiates Coverage On | 8 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Hold | $475.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.